Anzahl der Publikationen: 4
Zeitschriftenartikel
Napolitano, Valeria; Dabrowska, Agnieszka; Schorpp, Kenji; Mourao, Andre; Barreto-Duran, Emilia; Benedyk, Malgorzata; Botwina, Pawel; Brandner, Stefanie; Bostock, Mark; Chykunova, Yuliya; Czarna, Anna; Dubin, Grzegorz; Froehlich, Tony; Hoelscher, Michael; Jedrysik, Malwina; Matsuda, Alex; Owczarek, Katarzyna; Pachota, Magdalena; Plettenburg, Oliver; Potempa, Jan; Rothenaigner, Ina; Schlauderer, Florian; Slysz, Klaudia; Szczepanski, Artur; Mohn, Kristin Greve-Isdahl; Blomberg, Bjorn; Sattler, Michael; Hadian, Kamyar; Popowicz, Grzegorz Maria und Pyrc, Krzysztof
(2022):
Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses.
In: Cell Chemical Biology, Bd. 29, Nr. 5, E8: S. 774-784
Forstner, Maria; Lin, Sean; Yang, Xiaohua; Kinting, Susanna; Rothenaigner, Ina; Schorpp, Kenji; Li, Yang; Hadian, Kamyar und Griese, Matthias
(2022):
High-Content Screening Identifies Cyclosporin A as a Novel ABCA3-Specific Molecular Corrector.
In: American Journal of Respiratory Cell and Molecular Biology, Bd. 66, Nr. 4: S. 382-390
Costa, Rita; Wagner, Darcy E.; Doryab, Ali; De Santis, Martina M.; Schorpp, Kenji; Rothenaigner, Ina; Lehmann, Mareike; Baarsma, Hoeke A.; Liu, Xueping; Schmid, Otmar; Campillos, Monica; Yildirim, Ali Onder; Hadian, Kamyar und Koenigshoff, Melanie
(2021):
A drug screen with approved compounds identifies amlexanox as a novel Wnt/beta-catenin activator inducing lung epithelial organoid formation.
In: British Journal of Pharmacology, Bd. 178, Nr. 19: S. 4026-4041
Iturbide, Ane; Segura, Mayra L. Ruiz Tejeda; Noll, Camille; Schorpp, Kenji; Rothenaigner, Ina; Ruiz-Morales, Elias R.; Lubatti, Gabriele; Agami, Ahmed; Hadian, Kamyar; Scialdone, Antonio und Torres-Padilla, Maria-Elena
(2021):
Retinoic acid signaling is critical during the totipotency window in early mammalian development.
In: Nature Structural & Molecular Biology, Bd. 28, Nr. 6:
521-
Diese Liste wurde am
Sun May 12 02:26:55 2024 CEST
erstellt.